An allograft is a transplant of tissue or bone from one person to another. Unlike an organ transplant, which requires lifelong anti-rejection medication, most tissue allografts serve as a scaffold that your body gradually replaces with its own living tissue. Allografts are one of the most common tools in orthopedic surgery, dental procedures, and burn treatment, used in hundreds of thousands of procedures each year in the United States.
How Allografts Work in the Body
When a surgeon places an allograft, the donated tissue doesn’t stay permanently as a foreign object. Instead, your body treats it as a framework to build on. In the case of bone allografts, two processes drive this. First, the graft acts as a surface for your own bone cells to grow across, much like a trellis guides a vine. Second, proteins within the graft recruit immature cells from surrounding tissue and stimulate them to develop into bone-forming cells. Over weeks and months, your body lays down new living bone that gradually replaces the donor material.
This is why most tissue allografts don’t require the immunosuppressant drugs that organ transplants do. The processing and sterilization steps remove most of the donor’s living cells, which are the primary targets the immune system would recognize as foreign. What remains is largely structural protein and mineral, which your body can accept and remodel without mounting a significant immune response.
Types of Tissue Used
The range of tissues that can be transplanted as allografts is broader than most people realize. Common examples include bone, skin, corneas, heart valves, ligaments, veins, and tendons. Bone allografts are frequently used in spinal fusions, dental implants, and fracture repairs. Skin allografts can be lifesaving for severe burn patients, providing temporary coverage that protects against infection while the patient’s own skin heals or is grafted from another body site. Tendon and ligament allografts are a mainstay of sports medicine, particularly for reconstructing torn knee ligaments.
Allograft vs. Autograft
The main alternative to an allograft is an autograft, which uses tissue harvested from your own body. In an ACL knee reconstruction, for example, a surgeon might take a strip of your patellar tendon or hamstring tendon and use it to replace the torn ligament. Each approach has real trade-offs.
Autografts integrate faster because your immune system recognizes the tissue immediately. There’s no risk of disease transmission, and the tissue incorporates into its new location more quickly. The downside is donor-site morbidity, the pain and weakness at the spot where tissue was harvested. In one study, 53% of autograft patients reported complaints at the incision site, compared to just 7% of allograft patients. The harvest also adds surgical time and creates a second area of your body that needs to heal.
Allografts eliminate that second wound entirely. They allow shorter surgeries, less postoperative pain, and faster early rehabilitation. The trade-off is a small risk of disease transmission (more on that below) and slower biological incorporation. For younger, highly active patients, the difference in long-term durability can be significant. A meta-analysis of ACL reconstruction in patients 19 and younger found a pooled failure rate of 25.5% for allografts, compared to 8.5% for patellar tendon autografts and 16.6% for hamstring autografts. That nearly fourfold increase in failure risk is why many surgeons recommend autografts for young athletes who plan to return to high-demand sports.
Where Allografts Perform Best
The higher failure rate in young ACL patients doesn’t mean allografts are inferior across the board. Context matters enormously. In spinal fusion surgery, bone allografts perform exceptionally well. A large study tracking patients over two years found overall fusion success rates between 97% and 100%, regardless of whether the surgeon approached from the front, side, or back of the spine. The structural demands on a spinal bone graft are different from those on a reconstructed knee ligament in a teenager playing competitive soccer.
Allografts also shine in revision surgeries, where a previous repair has failed and the patient’s own tissue options are limited. They’re preferred when multiple grafts are needed in a single procedure, since harvesting that much tissue from the patient’s own body would create unacceptable damage. And for older or less active patients undergoing ligament reconstruction, the gap in failure rates between allografts and autografts narrows considerably.
Processing and Safety Standards
Before any allograft reaches an operating room, it goes through rigorous screening and sterilization. Donors are tested for infectious diseases including HIV, hepatitis B, and hepatitis C. The tissue itself is then processed using one or more sterilization methods. Gamma irradiation is the most common, typically delivered at a standardized dose that has been the international benchmark for decades. Other methods include chemical processing, antibiotic soaks, and electron-beam irradiation.
Processing is a balancing act. Higher radiation doses kill more pathogens but can weaken the tissue. At very high doses, torsion strength in bone grafts drops to about 65% of its original value. Freeze-drying, another common preservation technique, can further reduce mechanical properties when combined with irradiation. Tissue banks carefully calibrate their methods to sterilize effectively while preserving as much structural integrity as possible.
The result is an extremely low infection rate. Studies place the risk of disease transmission from a modern, properly processed allograft at well below 1%, with estimates ranging from 0.0004% to 0.014%. The theoretical concerns about HIV, hepatitis, and bacterial contamination remain real but are addressed by multiple overlapping layers of screening and sterilization.
What Recovery Looks Like
Recovery after allograft surgery depends heavily on what was repaired and where. A bone allograft used in spinal fusion has a very different recovery timeline than a cartilage allograft in the knee. But knee procedures offer a useful illustration of the general pattern, since they’re among the most common.
For the first six weeks after a knee cartilage allograft, you’re typically limited to partial weight-bearing, starting with barely touching your toe to the ground and progressing to about 50%. A brace limits your range of motion initially, and the focus is on controlling swelling and gently restoring movement. By six to twelve weeks, the goal shifts to achieving full, pain-free range of motion and discontinuing the brace. You’ll begin putting more weight on the leg, progressing to full weight-bearing by around eight weeks.
From three to six months, rehabilitation centers on normalizing your walking pattern, building strength, and improving balance. The graft is still maturing during this period, and high-impact activities remain off-limits. After six months, sport-specific training can begin, but only after imaging confirms the graft has healed. For many patients, full return to unrestricted activity takes closer to nine to twelve months. The timeline is generally longer than for autografts in the early phases, because allograft tissue incorporates more slowly than your body’s own tissue would.